Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Dermatitis 1Anus Neoplasms 1

Interventions

pembrolizumab 5Cyclophosphamide 5fludarabine 4Radiotherapy 4Irinotecan 4Mitomycin 3Interleukin-12 Subunit p35 3Fluorouracil 3Capecitabine 3Trastuzumab 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Erlotinib Hydrochloride 2Cetuximab 2Carboplatin 2tipifarnib 1tempol 1prexasertib 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1Vorinostat 1Vaccines 1Thalidomide 1Taxes 1Surveys and Questionnaires 1Specimen Handling 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Papillomavirus Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Anus Neoplasms × tempol × Clear all
NCT01324141 2021-11-23

Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
6 enrolled 28 charts
Gastrointestinal

Anus Neoplasms, Dermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡